Encyclopedia of Cancer

Living Edition
| Editors: Manfred Schwab

Syk Tyrosine Kinase

  • Susette C. Mueller
  • Peter J. Coopman
Living reference work entry
DOI: https://doi.org/10.1007/978-3-642-27841-9_5616-3



Syk tyrosine kinase activity was originally recognized in the spleen, thymus, and lung and was later cloned from spleen. A 72 kDa protein, Syk contains 635 amino acids and the human gene maps to chromosome 9q22. It contains two N-terminal, SH2 domains in tandem and a C-terminal tyrosine kinase domain. Interdomain A separates the tandem SH2 domains, and interdomain B links the kinase domain to the tandem SH2 domains. An alternatively spliced site in interdomain B deleting 23 amino acids gives rise to a short form of Syk that can be differently expressed according to the tissue. Syk together with the related Zap70 (zeta-activated protein of 70 kDa) constitute a separate tyrosine kinase family.


Distribution and Function

Syk is critical to immune cell signaling where it promotes proliferation, survival, phagocytosis, and differentiation and is required for lymphocyte development, innate immune recognition, osteoclast...


Mantle Cell Lymphoma Oral Squamous Cell Carcinoma Epigenetic Gene Silence Breast Cancer Patient Outcome Transmembrane Integrin Receptor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.


  1. Abram CL, Lowell CA (2007a) Convergence of immunoreceptor and integrin signaling. Immunol Rev 218:29–44CrossRefPubMedGoogle Scholar
  2. Abram CL, Lowell CA (2007b) The expanding role for ITAM-based signaling pathways in immune cells. Sci STKE 337:re2Google Scholar
  3. Blancato J, Graves A, Rashidi B, Moroni M, Tchobe L, Ozdemirli M, Kallakury B, Makambi KH, Marian C, Mueller SC (2014) SYK allelic loss and the role of Syk-regulated genes in breast cancer survival. PLoS One 9:e87610CrossRefPubMedPubMedCentralGoogle Scholar
  4. Coopman PJ, Mueller SC (2006) The Syk tyrosine kinase: a new negative regulator in tumor growth and progression. Cancer Lett 241:159–173CrossRefPubMedGoogle Scholar
  5. Coopman PJ, Do MT, Barth M, Bowden ET, Hayes AJ, Basyuk E, Blancato JK, Vezza PR, McLeskey SW, Mangeat PH, Mueller SC (2000) The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature 406:742–747CrossRefPubMedGoogle Scholar
  6. Geahlen RL (2009) Syk and pTyr’d: signaling through the B cell antigen receptor. Biochim Biophys Acta 1793:1115–1127CrossRefPubMedPubMedCentralGoogle Scholar
  7. Geahlen RL (2014) Getting Syk: spleen tyrosine kinase as a therapeutic target. Trends Pharmacol Sci 35:414–422CrossRefPubMedPubMedCentralGoogle Scholar
  8. Ghosh D, Tsokos GC (2010) Spleen tyrosine kinase: an Src family of non-receptor kinase has multiple functions and represents a valuable therapeutic target in the treatment of autoimmune and inflammatory diseases. Autoimmunity 43:48–55CrossRefPubMedGoogle Scholar
  9. Kerrigan AM, Brown GD (2010) Syk-coupled C-type lectin receptors that mediate cellular activation via single tyrosine based activation motifs. Immunol Rev 234:335–352CrossRefPubMedGoogle Scholar
  10. Mócsai A, Ruland J, Tybulewicz VL (2010) The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat Rev Immunol 10:387–402CrossRefPubMedPubMedCentralGoogle Scholar
  11. Turner M, Schweighoffer E, Colucci F et al (2000) Tyrosine kinase SYK: essential functions for immunoreceptor signalling. Immunol Today 21:148–154CrossRefPubMedGoogle Scholar
  12. Wang Y, Yu Q, Cho AH et al (2005) Survey of differentially methylated promoters in prostate cancer cell lines. Neoplasia 7:748–760CrossRefPubMedPubMedCentralGoogle Scholar
  13. Yang Z, Huo L, Chen H, Ni B, Xiang J, Kang L, Wang L, Peng J, Yuan Y, Wang J (2013) Hypermethylation and prognostic implication of Syk gene in human colorectal cancer. Med Oncol 30:586CrossRefPubMedGoogle Scholar
  14. Yuan Y, Wang J, Li J et al (2006) Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma. Clin Cancer Res 12:6687–6695CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Lombardi Comprehensive Cancer CenterGeorgetown University Medical CenterWashingtonUSA
  2. 2.IRCM, INSERM U1194Montpellier Cancer Research InstituteMontpellierFrance